Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SERTRALINE | 100MG | CAPSULE | Actual shortage | 2024-05-24 | 2024-05-24 | 228786 |
APO-ATOMOXETINE | 100MG | CAPSULE | Actual shortage | 2024-05-24 | 2024-05-24 | 228792 |
APO-RIVAROXABAN | 15MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228801 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-05-24 | 2024-06-14 | 228804 |
APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Actual shortage | 2024-05-24 | 2024-06-14 | 228807 |
APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2024-05-24 | 2024-05-31 | 228810 |
APO-CLOPIDOGREL | 300MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228813 |
APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2024-05-24 | 2024-06-07 | 228816 |
APO-ANASTROZOLE | 1MG | TABLET | Actual shortage | 2024-05-30 | 2024-06-13 | 229161 |
APO-ATOMOXETINE | 25MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229164 |
APO-ATOMOXETINE | 40MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229167 |
APO-ALLOPURINOL | 300MG | TABLET | Actual shortage | 2024-05-31 | 2024-05-31 | 229389 |
APO-MIRTAZAPINE | 15MG | TABLET | Actual shortage | 2024-05-31 | 2024-06-06 | 229392 |
APO-ARIPIPRAZOLE | 15MG | TABLET | Actual shortage | 2024-05-31 | 2024-05-31 | 229395 |
APO-TICAGRELOR | 60MG | TABLET | Actual shortage | 2024-05-31 | 2024-06-13 | 229398 |
APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229401 |
APO-AMLODIPINE-ATORVASTATIN | 40MG 5MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229404 |
APO-CINACALCET | 30MG | TABLET | Actual shortage | 2024-05-31 | 2024-05-31 | 229407 |
APO-ACEBUTOLOL | 400MG | TABLET | Actual shortage | 2024-05-31 | 2024-05-31 | 229410 |
APO-PRAVASTATIN | 10MG | TABLET | Actual shortage | 2024-05-31 | 2024-06-14 | 229413 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |